DK1673370T3 - Krystallingsk form af linezolid - Google Patents

Krystallingsk form af linezolid

Info

Publication number: DK1673370T3
Authority: DK; Denmark
Prior art keywords: linezolid; crystalline form; preparation; relates; present
Prior art date: 2003-10-16

Application number

DK03769887T

Other languages

English (en)

Inventor

Rao Dodda Mohan

Reddy Pingili Krishna

Original Assignee

Symed Labs Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-16

Filing date

2003-10-16

Publication date

2009-12-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1673370(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-16 Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd

2009-12-07 Application granted granted Critical

2009-12-07 Publication of DK1673370T3 publication Critical patent/DK1673370T3/da

Links

TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 title abstract 2
229960003907 linezolid Drugs 0.000 title abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Photoreceptors In Electrophotography (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK03769887T 2003-10-16 2003-10-16 Krystallingsk form af linezolid DK1673370T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IN2003/000336 WO2005035530A1 (en)	2003-10-16	2003-10-16	A novel crystalline form of linezolid

Publications (1)

Publication Number	Publication Date
DK1673370T3 true DK1673370T3 (da)	2009-12-07

Family

ID=34430675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03769887T DK1673370T3 (da)	2003-10-16	2003-10-16	Krystallingsk form af linezolid

Country Status (10)

Country	Link
US (4)	US7714128B2 (da)
EP (3)	EP2902386B1 (da)
AT (1)	ATE442364T1 (da)
AU (1)	AU2003278592A1 (da)
DE (2)	DE09163348T1 (da)
DK (1)	DK1673370T3 (da)
ES (3)	ES2803516T3 (da)
HU (1)	HUE051230T2 (da)
PT (1)	PT1673370E (da)
WO (1)	WO2005035530A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2803516T3 (es)	2003-10-16	2021-01-27	Symed Labs Ltd	Una forma cristalina de linezolid
WO2005099353A2 (en)	2004-04-19	2005-10-27	Symed Labs Limited	A novel process for the preparation of linezolid and related compounds
US20060142283A1 (en) *	2004-06-29	2006-06-29	Judith Aronhime	Crystalline form IV of linezolid
US20060111350A1 (en) *	2004-06-29	2006-05-25	Judith Aronhime	Solid forms of linezolid and processes for preparation thereof
WO2006091731A2 (en) *	2005-02-24	2006-08-31	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of linezolid intermediate
DK1749517T3 (da) *	2005-07-20	2008-11-03	Teva Pharma	Stabil farmaceutiske sammensætning af linezolid form IV
EP2033960A3 (en)	2007-09-04	2009-04-29	Dipharma Francis S.r.l.	Linezolid crystalline hydrate form and linezolid salts
IT1390957B1 (it) *	2008-07-07	2011-10-27	Dipharma Francis Srl	Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
US20090093631A1 (en) *	2007-09-06	2009-04-09	Ben-Zion Dolitzky	Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) *	2008-05-14	2009-11-19	Dr. Reddy's Laboratories Ltd.	Linezolid co-crystals
EP2493867A1 (en)	2009-10-28	2012-09-05	Synthon BV	Process for making crystalline form a of linezolid
WO2011050826A1 (en) *	2009-10-28	2011-05-05	Synthon B.V.	Process for making crystalline form a of linezolid
EP2516408A1 (en)	2009-12-26	2012-10-31	Alembic Pharmaceuticals Limited	Process for the preparation of linezolid
CN103140487A (zh)	2010-08-11	2013-06-05	斯索恩有限公司	制备利奈唑胺的方法
EP2690100A1 (en)	2010-08-11	2014-01-29	Synhton B.V.	Process for making linezolid
WO2012029074A2 (en)	2010-09-02	2012-03-08	Hetero Research Foundation	Pharmaceutical compositions of linezolid
CN102070548B (zh) *	2011-01-13	2012-12-26	浙江新东港药业股份有限公司	一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
WO2012114354A1 (en)	2011-02-24	2012-08-30	Lee Pharma Limited	Anhydrous linezolid crystalline form-ii
WO2012119653A1 (en)	2011-03-09	2012-09-13	Synthon Bv	Process for making crystalline form a of linezolid
CN102766106A (zh) *	2011-05-03	2012-11-07	江苏豪森医药集团有限公司	利奈唑胺的新晶型及其制备方法
ITMI20111311A1 (it) *	2011-07-14	2013-01-15	Dipharma Francis Srl	Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en)	2011-09-19	2013-05-23	Cadila Healthcare Limited	Process for the preparation of crystalline linezolid
WO2013093751A1 (en) *	2011-12-24	2013-06-27	Alembic Pharmaceuticals Limited	Packaging for linezolid
EP2852580A1 (en)	2012-01-24	2015-04-01	Jubilant Life Sciences Ltd.	Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en)	2012-02-14	2013-08-22	Pharmathen S.A.	Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) *	2012-06-19	2013-12-27	Symed Labs Limited	Improved processes for the preparation of linezolid crystalline form iii
US9492459B2 (en) *	2012-08-10	2016-11-15	Indoco Remedies Limited	Pharmaceutical composition of linezolid
WO2014071990A1 (en)	2012-11-09	2014-05-15	Synthon Bv	Process for making linezolid
WO2014118809A1 (en)	2013-01-29	2014-08-07	Actavis Group Ptc Ehf.	Pharmaceutical composition with linezolid
IN2013MU03508A (da)	2013-11-06	2015-07-24	Unimark Remedies Ltd
CN105254580B (zh) *	2014-04-22	2018-01-02	江苏豪森药业集团有限公司	利奈唑胺晶型的制备方法
IN2015CH00214A (da) *	2015-01-13	2015-04-24	Nosch Labs Private Ltd
WO2018051360A1 (en) *	2016-09-16	2018-03-22	Lee Pharma Limited	A novel process for the preparation of crystalline linezolid form-iii
SG11202003537TA (en)	2017-11-16	2020-05-28	Persica Pharmaceuticals Ltd	Linezolid formulations
CN110194750A (zh) *	2019-06-19	2019-09-03	四川美大康华康药业有限公司	一种利奈唑胺的制备方法及精制方法
WO2023062080A1 (en)	2021-10-12	2023-04-20	Persica Pharmaceuticals Ltd.	Low back pain treatment

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US583870A (en) *		1897-06-01		Wrench
DE2810349A1 (de)	1978-03-10	1979-09-20	Kali Chemie Pharma Gmbh	Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr)	1978-06-09	1982-12-03	Delalande Sa	Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en)	1980-10-23	1982-07-20	E. I. Du Pont De Nemours And Company	3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr)	1986-12-19	1989-04-28	Delalande Sa	Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en)	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives
DE9310451U1 (de)	1993-03-05	1994-06-30	Landis & Gyr Business Support Ag, Zug	Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
EP0615095B1 (de)	1993-03-11	1997-05-07	Landis & Gyr Technology Innovation AG	Brennerregler
MY115155A (en)	1993-09-09	2003-04-30	Upjohn Co	Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en)	1994-08-16	1997-11-18	Pharmacia & Upjohn Company	Substituted oxazine and thiazine oxazolidinone antimicrobials
SK284703B6 (sk)	1996-04-11	2005-09-08	Pharmacia & Upjohn Company	Spôsob prípravy substituovaných oxazolidinón alkoholov
EP0890791A1 (de)	1997-07-11	1999-01-13	Electrowatt Technology Innovation AG	Steuer- und Regelgerät für einen Brenner
KR100580408B1 (ko)	1997-11-07	2006-05-16	파마시아 앤드 업존 캄파니 엘엘씨	옥사졸리디논의 제조 방법
US6444813B2 (en) *	2000-02-02	2002-09-03	Pharmacia & Upjohn Company	Linezolid-crystal form II
AR027261A1 (es)	2000-02-02	2003-03-19	Upjohn Co	Linezolid forma cristalina ii
MY127336A (en)	2000-03-22	2006-11-30	Upjohn Co	Container for linezolid iv solution
DE10037585A1 (de) *	2000-08-02	2002-02-14	Valeo Schalter & Sensoren Gmbh	Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
WO2002014286A1 (en) *	2000-08-14	2002-02-21	Teva Pharmaceutical Industries Ltd.	Preparation of risperidone
JP2004520432A (ja) *	2001-02-05	2004-07-08	ファルマシア・アンド・アップジョン・カンパニー	オキサゾリジノン抗菌薬の直腸送達のための組成物
JP2005504007A (ja)	2001-04-20	2005-02-10	ファルマシアアンドアップジョンカンパニーリミティドライアビリティーカンパニー	オキサゾリジノンの製法
CN1155585C (zh)	2001-12-19	2004-06-30	中国医学科学院医药生物技术研究所	3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) *	2002-08-09	2006-01-31	Cephalon France	Modafinil polymorphic forms
ES2803516T3 (es)	2003-10-16	2021-01-27	Symed Labs Ltd	Una forma cristalina de linezolid
WO2005099353A2 (en)	2004-04-19	2005-10-27	Symed Labs Limited	A novel process for the preparation of linezolid and related compounds
US20060142283A1 (en) *	2004-06-29	2006-06-29	Judith Aronhime	Crystalline form IV of linezolid
US7429661B2 (en)	2004-07-20	2008-09-30	Symed Labs Limited	Intermediates for linezolid and related compounds

2003
- 2003-10-16 ES ES15155714T patent/ES2803516T3/es not_active Expired - Lifetime
- 2003-10-16 DK DK03769887T patent/DK1673370T3/da active
- 2003-10-16 HU HUE15155714A patent/HUE051230T2/hu unknown
- 2003-10-16 EP EP15155714.7A patent/EP2902386B1/en not_active Expired - Lifetime
- 2003-10-16 AT AT03769887T patent/ATE442364T1/de active
- 2003-10-16 ES ES03769887T patent/ES2331001T3/es not_active Expired - Lifetime
- 2003-10-16 US US10/524,478 patent/US7714128B2/en active Active
- 2003-10-16 DE DE2009163348 patent/DE09163348T1/de active Pending
- 2003-10-16 WO PCT/IN2003/000336 patent/WO2005035530A1/en active Application Filing
- 2003-10-16 PT PT03769887T patent/PT1673370E/pt unknown
- 2003-10-16 ES ES09163348T patent/ES2331454T1/es active Pending
- 2003-10-16 DE DE60329237T patent/DE60329237D1/de not_active Expired - Lifetime
- 2003-10-16 AU AU2003278592A patent/AU2003278592A1/en not_active Abandoned
- 2003-10-16 EP EP03769887A patent/EP1673370B1/en not_active Revoked
- 2003-10-16 EP EP20090163348 patent/EP2100884A1/en not_active Withdrawn
2007
- 2007-09-26 US US11/861,340 patent/US7718799B2/en not_active Expired - Fee Related
- 2007-09-26 US US11/861,433 patent/US7718800B2/en not_active Expired - Fee Related
- 2007-09-26 US US11/861,406 patent/US7732597B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2331001T3 (es)	2009-12-18
EP2100884A1 (en)	2009-09-16
DE60329237D1 (de)	2009-10-22
WO2005035530A1 (en)	2005-04-21
ATE442364T1 (de)	2009-09-15
US7714128B2 (en)	2010-05-11
ES2803516T3 (es)	2021-01-27
DE09163348T1 (de)	2010-01-07
US7718799B2 (en)	2010-05-18
US20080091011A1 (en)	2008-04-17
US7718800B2 (en)	2010-05-18
EP2902386A1 (en)	2015-08-05
EP1673370B1 (en)	2009-09-09
EP1673370A1 (en)	2006-06-28
PT1673370E (pt)	2009-11-05
US7732597B2 (en)	2010-06-08
HUE051230T2 (hu)	2021-03-01
EP2902386B1 (en)	2020-04-08
AU2003278592A1 (en)	2005-04-27
US20080090820A1 (en)	2008-04-17
US20080090824A1 (en)	2008-04-17
ES2331454T1 (es)	2010-01-05
US20060128703A1 (en)	2006-06-15

Publication	Publication Date	Title
DK1673370T3 (da)	2009-12-07	Krystallingsk form af linezolid
IS7007A (is)	2003-10-30	Kristallaform af asiþrómýsíni
DK1856135T3 (da)	2010-04-12	Prodrugs af 2,4-pyrimidindiamin-forbindelser og deres anvendelser
CY2013036I2 (el)	2015-12-09	Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
DE60315368D1 (de)	2007-09-20	Korrektur des Weissabgleichs
IS3027B (is)	2021-03-15	Hraðuppleysandi samsetning af kalsíum viðtaka-virku efnasambandi
DK2363414T3 (da)	2022-08-08	Stedstyret modifikation af FVIII
ATE428701T1 (de)	2009-05-15	Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
SE0302305D0 (sv)	2003-08-27	Novel Compounds
DK1476162T3 (da)	2007-07-02	Kontrolleret syntese af ziprasidone
DK1603524T3 (da)	2011-11-21	Enzymholdig oral sammensætning med forbedret stabilitet
ATE352546T1 (de)	2007-02-15	Kristalline zusammensetzung enthaltend escitalopram
DK1840125T3 (da)	2009-11-09	Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1380121T3 (da)	2007-12-27	Fremgangsmåde til fremstilling af oxazolidinoner
DE60111497D1 (de)	2005-07-21	Linezolid-krystall form ii
ATE364610T1 (de)	2007-07-15	Kristalline polymorphe form von irinotecan- hyrochlorid
EA200801365A1 (ru)	2008-10-30	Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
DK1597232T3 (da)	2007-01-29	Ny krystallinsk modifikation af anhydratet af boscalid
DK1578774T3 (da)	2014-02-03	Oprensning af immunoglobuliner
DK1644385T3 (da)	2008-01-02	Siliciumforbindelser og deres anvendelse
DK1250918T3 (da)	2007-06-11	Kosmetiske sammensætninger indeholdende ekstrakter af urbakterier
IS7195A (is)	2004-03-23	Ný vatnsfrí kristallaform af gabapentíni
EE05246B1 (et)	2009-12-15	Fungitsiididena kasutatavad oksasiin(ti)oonhendid
DK1571901T3 (da)	2013-03-11	Fremstilling af planter med ændret olieindhold
ATE328595T1 (de)	2006-06-15	Carvedilolpolymorph